A Promising Treatment For Spinal Cord Injuries
Our expert discusses a new option that, if FDA approved, could be a gamechanger for patients.
Radio Health Journal
The latest in health, science, technology, and the intersection of medicine and public policy.
NervGen Pharma Corp.
Radio Health Journal Newsletter SignupStay up-to-date on the latest trends in public health, science, tech, research & more.
Subscribe to get the latest from Radio Health Journal directly in your inbox.
